LUDG.png
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers
March 06, 2024 08:00 ET | Ludwig Enterprises, Inc.
Ludwig Enterprises, Inc. (OTC: LUDG): A US-based biotechnology company is pleased to announce the successful filing of its provisional patent
logo.jpg
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
February 06, 2024 08:30 ET | Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
1ProLynx LOGO.png
ProLynx announces initiation of Phase I/II clinical trial of its DNA-damaging agent PLX038 in patients with rare CNS tumors at the National Cancer Institute (NCI)
February 05, 2024 09:00 ET | ProLynx Inc.
SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc. announced today that the first patient was treated with PLX038 (PEGylated SN-38) in a Phase I/II clinical trial for primary CNS tumors...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Radiotherapy Market to grow by USD 12.2 billion by 2033, Globally at 5.9% CAGR | Market.us
January 29, 2024 07:10 ET | Market.Us
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global radiotherapy market size is forecasted to exceed USD 12.2 billion by 2033, with a promising CAGR of 5.9% from 2024 to...
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Photodynamic Therapy Market Set to Hit USD 5.53 Billion by 2033 | Boosting Opportunities for Medical Innovations
January 18, 2024 06:51 ET | Market.Us
New York, Jan. 18, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Photodynamic therapy market size is projected to surpass around USD 5.53 Billion by 2033, and it is poised to reach a...
Fairfield Market Research Logo (1).JPG
Multi-Cancer Early Detection Market Size to Reach US$2.5 Bn by 2030, Fairfield Market Research Indicates Europe’s Leadership
December 13, 2023 08:56 ET | Fairfield Consultancy Services OPC Pvt Ltd
London, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The global multi-cancer early detection market, presently valued at approximately US$0.89 Bn, is projected to witness an impressive CAGR of 16.3% through...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Shares Pharmacokinetic and Baseline Genomic Clinical Data Tied to ELAINE Lasofoxifene Trials of Patients With ESR1 Mutations
December 12, 2023 09:00 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology
December 11, 2023 09:00 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast...
TeleDaas_Logo_Colour FINAL.png
TeleDaaS™ Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations
November 26, 2023 08:00 ET | TeleDaas PLLC
TeleDaaS revolutionizes radiopharmaceutical research by delivering highly-scalable, clinical-grade dosimetry to accelerate cancer treatment breakthroughs.
Turnstone Logo.jpg
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
November 09, 2023 21:49 ET | Turnstone Biologics Corp.
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights